Mountain Valley MD files patent and begins pre-clinical trials to enter USD $100 billion cancer drug market – PRNewswire
Mountain Valley MD files patent and begins pre-clinical trials to enter USD $100 billion cancer drug market PRNewswire
Archive for May, 2021
-
In: PATENT NEWS
-
In: PATENT NEWS
Merck Asks Court to Declare Nexplanon Doesn’t Infringe Patent – Bloomberg Law
Merck Asks Court to Declare Nexplanon Doesn’t Infringe Patent Bloomberg Law
-
In: PATENT NEWS
The Russian Ministry of Justice introduces a new option for forensic examinations in intellectual …
Under the current legislation, the parties may recommend experts for performing the assessment of intellectual property objects to the court, …
-
In: PATENT NEWS
Merck Asks Court to Declare Nexplanon Doesn’t Infringe Patent
IP Law. Merck Asks Court to Declare Nexplanon Doesn’t Infringe Patent. By …
-
In: PATENT NEWS
The question of embryohood
The definition of the embryo is important in patent law, as the European Biotechnology Directive rightly excludes from patentability ‘uses of human …
-
In: COPYRIGHT NEWS
8 Things Not to Say to Someone Estranged from a Parent – Psychology Today
8 Things Not to Say to Someone Estranged from a Parent Psychology Today
-
In: PATENT NEWS
How the next Patent Office director could shape the patent system – Ars Technica
How the next Patent Office director could shape the patent system Ars Technica
-
In: DESIGN NEWS
Future100: Guillermo Hevia’s Design Is an Exploration of Scale
Chilean architect Guillermo Hevia practiced for seven years in his home country before enrolling at Columbia. “During my time at GSAPP, I discovered …
-
In: COPYRIGHT NEWS
Nirvana Sued for Copyright Infringement Over Use of Dante’s ‘Inferno’ Illustration – Rolling Stone
Nirvana Sued for Copyright Infringement Over Use of Dante’s ‘Inferno’ Illustration Rolling Stone
-
In: PATENT NEWS
Patent Granted to Aquavit for Novel RoA and MoA for Bioactive Compositions – PRNewswire
Patent Granted to Aquavit for Novel RoA and MoA for Bioactive Compositions PRNewswire